Overview

  • Product nameAM1241
  • Description
    Potent, selective CB2 agonist
  • Biological descriptionPotent, selective CB2 agonist (Ki = 7.1 nM). Efficacious in vivo, broad-spectrum antinociceptive effects.
  • Purity> 97%

Properties

    References for AM1241 (ab120934)

    This product has been referenced in:
    • Wilkerson JL  et al. Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia. Brain Behav 2:155-77 (2012). Read more (PubMed: 22574283) »
    • Bingham B  et al. Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers. Br J Pharmacol 151:1061-70 (2007). Read more (PubMed: 17549048) »
    • Yao BB  et al. In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor? Br J Pharmacol 149:145-54 (2006). Read more (PubMed: 16894349) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120934.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"